No Data
Express News | Merck & Co.'s respiratory syncytial virus (RSV) preventive monoclonal antibody, Winrevair (ceralivimab), has been approved in China.
CMS Proposes Making Medicare Drug Price Negotiations Permanent
Merck & Co Options Spot-On: On June 12th, 175.74K Contracts Were Traded, With 535.33K Open Interest
On June 12th ET, $Merck & Co(MRK.US)$ had active options trading, with a total trading volume of 175.74K options for the day, of which put options accounted for 2.49% of the total transactions, and
Catalyst Watch: G7 Drama, Retail Sales, and Warsh's First Fed Meeting
Best ETFs to Invest In, According to AI Analyst, 6/12/2026
Amgen, Honeywell Share Gains Lead Dow's 265-Point Jump